Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits

Open access

Abstract

BACKGROUND: Preventing or reducing amyloid-beta (Aβ) accumulation in the brain is an important therapeutic strategy for Alzheimer's disease (AD). Recent studies showed that the water channel aquaporin-4 (AQP4) mediates soluble Aβ clearance from the brain parenchyma along the paravascular pathway. However the direct evidence for roles of AQP4 in the pathophysiology of AD remains absent. RESULTS: Here, we reported that the deletion of AQP4 exacerbated cognitive deficits of 12-moth old APP/PS1 mice, with increases in Aβ accumulation, cerebral amyloid angiopathy and loss of synaptic protein and brain-derived neurotrophic factor in the hippocampus and cortex. Furthermore, AQP4 deficiency increased atrophy of astrocytes with significant decreases in interleukin-1 beta and nonsignificant decreases in interleukin-6 and tumor necrosis factor-alpha in hippocampal and cerebral samples. CONCLUSIONS: These results suggest that AQP4 attenuates Aβ pathogenesis despite its potentially inflammatory side-effects, thus serving as a promising target for treating AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-015-0056-1

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 AQP4 deficiency aggravated cognitive impairment in 12 month-old APP/PS1 mice. a The mean escape latency, and b swimming speed during the hidden platform training period of the Morris water maze test. c Tracings of the typical swim patterns. d The percentage of time spent in the target quadrant. e The number of crossing the platform area. f The percentage of time spent in the novel arm. g The number of entries into the novel arm in the Y-maze. Data represent mean ± SEM from 9 to 11 mice (6–8 female, and 3–5 male) per group. Data in Fig. 1a and b were analyzed by repeated-measures ANOVA with post hoc Student-Newman-Keuls test, *P < 0.05, AQP4−/−APP/PS1 mice vs APP/PS1 mice; #P < 0.05, APP/PS1 mice vs WT mice; ^P < 0.05, AQP4−/− mice vs WT mice. Data in Fig. 1d-g were analyzed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 1 AQP4 deficiency aggravated cognitive impairment in 12 month-old APP/PS1 mice. a The mean escape latency, and b swimming speed during the hidden platform training period of the Morris water maze test. c Tracings of the typical swim patterns. d The percentage of time spent in the target quadrant. e The number of crossing the platform area. f The percentage of time spent in the novel arm. g The number of entries into the novel arm in the Y-maze. Data represent mean ± SEM from 9 to 11 mice (6–8 female, and 3–5 male) per group. Data in Fig. 1a and b were analyzed by repeated-measures ANOVA with post hoc Student-Newman-Keuls test, *P < 0.05, AQP4−/−APP/PS1 mice vs APP/PS1 mice; #P < 0.05, APP/PS1 mice vs WT mice; ^P < 0.05, AQP4−/− mice vs WT mice. Data in Fig. 1d-g were analyzed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001CC BY · PubMed Central
Fig. 2 AQP4 deficiency increased brain Aβ accumulation and CAA in 12 month-old APP/PS1 mice. a Aβ deposition in the hippocampus and cortex stained by 6E10 and Thioflavin-S. b High magnification micrographs of 6E10 immunostaining. There was increased amyloid deposition along small and large vessels in the brain parenchyma (arrowheads) and leptomeningeal vessels (stars) of AQP4−/−APP/PS1 mice, compared to APP/PS1 controls. c The area percentage of 6E10-positive Aβ plaque load in the hippocampus (HC) and cerebral cortex. d The area percentage of Thioflavin-S-positive Aβ plaque load in the hippocampus (HC) and cerebral cortex. e 6E10-immunoreactive (IR) intensity on the cortical vessels and leptomeningeal vessels. f-i ELISA analysis of soluble and insoluble Aβ1–40 and Aβ1–42 in the brain samples. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 2 AQP4 deficiency increased brain Aβ accumulation and CAA in 12 month-old APP/PS1 mice. a Aβ deposition in the hippocampus and cortex stained by 6E10 and Thioflavin-S. b High magnification micrographs of 6E10 immunostaining. There was increased amyloid deposition along small and large vessels in the brain parenchyma (arrowheads) and leptomeningeal vessels (stars) of AQP4−/−APP/PS1 mice, compared to APP/PS1 controls. c The area percentage of 6E10-positive Aβ plaque load in the hippocampus (HC) and cerebral cortex. d The area percentage of Thioflavin-S-positive Aβ plaque load in the hippocampus (HC) and cerebral cortex. e 6E10-immunoreactive (IR) intensity on the cortical vessels and leptomeningeal vessels. f-i ELISA analysis of soluble and insoluble Aβ1–40 and Aβ1–42 in the brain samples. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. *P < 0.05; **P < 0.01; ***P < 0.001CC BY · PubMed Central
Fig. 3 AQP4 deficiency did not alter expression of brain Aβ formation and degradation-related proteins in 12 month-old APP/PS1 mice. a Representative bands of Western bolt and b densitometry analysis of protein levels of APP and its proteolytic amyloidogenic fragments. c Representative bands of Western bolt and d densitometry analysis of protein levels of the biochemical components involved in the amyloid production (BACE1 and PS1) and degradation (IDE and NEP). Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test
Fig. 3 AQP4 deficiency did not alter expression of brain Aβ formation and degradation-related proteins in 12 month-old APP/PS1 mice. a Representative bands of Western bolt and b densitometry analysis of protein levels of APP and its proteolytic amyloidogenic fragments. c Representative bands of Western bolt and d densitometry analysis of protein levels of the biochemical components involved in the amyloid production (BACE1 and PS1) and degradation (IDE and NEP). Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-testCC BY · PubMed Central
Fig. 4 AQP4 deficiency increased astrocyte atrophy with attenuation of reactive gliosis and neuroinflammation in 12 month-old APP/PS1 mice. a GFAP positive reactive astrogliosis was significantly attenuated in the hippocampus and cerebral cortex of AQP4−/−APP/PS1 mice compared with APP/PS1 controls. A mild reduction of iba-1 positive reactive microgliosis also occurred in AQP4−/−APP/PS1 mouse brain. b The high magnification images showing that Congo Red positive plaques were surrounded by activated GFAP-positive astrocytes, displaying morphological features of hypertrophy, in APP/PS1 mice. In contrast, astrocytes adjacent to plaques exhibited atrophy with weak GFAP expression in AQP4−/−APP/PS1 mice. The reactive microgliosis around plaques was mildly reduced in AQP4−/−APP/PS1 mice, compared that in APP/PS1 controls. c The percentage of GFAP or Iba-1 positive area in the hippocampus and cortex. d GFAP-positive surface area per astrocyte and Iba-1-positive surface area per microglial cell surrounding Aβ plaques within the cortex. e Representative bands of Western bolt and f densitometry analysis of GFAP and Iba-1 protein levels in the hippocampus and cortex. g ELISA analysis of IL-1β, IL-6 and TNF-α levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. Data in Fig. 4c and d were analyzed by Student’s t-test and in Fig. 4f and g by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 4 AQP4 deficiency increased astrocyte atrophy with attenuation of reactive gliosis and neuroinflammation in 12 month-old APP/PS1 mice. a GFAP positive reactive astrogliosis was significantly attenuated in the hippocampus and cerebral cortex of AQP4−/−APP/PS1 mice compared with APP/PS1 controls. A mild reduction of iba-1 positive reactive microgliosis also occurred in AQP4−/−APP/PS1 mouse brain. b The high magnification images showing that Congo Red positive plaques were surrounded by activated GFAP-positive astrocytes, displaying morphological features of hypertrophy, in APP/PS1 mice. In contrast, astrocytes adjacent to plaques exhibited atrophy with weak GFAP expression in AQP4−/−APP/PS1 mice. The reactive microgliosis around plaques was mildly reduced in AQP4−/−APP/PS1 mice, compared that in APP/PS1 controls. c The percentage of GFAP or Iba-1 positive area in the hippocampus and cortex. d GFAP-positive surface area per astrocyte and Iba-1-positive surface area per microglial cell surrounding Aβ plaques within the cortex. e Representative bands of Western bolt and f densitometry analysis of GFAP and Iba-1 protein levels in the hippocampus and cortex. g ELISA analysis of IL-1β, IL-6 and TNF-α levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. Data in Fig. 4c and d were analyzed by Student’s t-test and in Fig. 4f and g by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001CC BY · PubMed Central
Fig. 5 AQP4 deficiency decreased LRP1 expression by astrocytes surrounding Aβ plaques in APP/PS1 mice. a Activated GFAP-positive (green) astrocytes surrounding plaque-like structures (blue) clearly expressed LRP1 (red) (arrowheads) in 12-month old APP/PS1 mice. In contrast, in age-matching AQP4−/−APP/PS1 mice, GFAP-positive astrocytes around plaques were atrophy with very low immunofluorescent staining of LRP1 (arrowheads). Some cells negative for GFAP (stars), expressed LRP1 in the both gene-type brains. b The percentage of LRP1 positive area within a radius of 100 μm to the plaque border. c The percentage of LRP1 and GFAP double positive area. d The percentage of LRP1 positive, but GFAP negative area. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. ***P < 0.001
Fig. 5 AQP4 deficiency decreased LRP1 expression by astrocytes surrounding Aβ plaques in APP/PS1 mice. a Activated GFAP-positive (green) astrocytes surrounding plaque-like structures (blue) clearly expressed LRP1 (red) (arrowheads) in 12-month old APP/PS1 mice. In contrast, in age-matching AQP4−/−APP/PS1 mice, GFAP-positive astrocytes around plaques were atrophy with very low immunofluorescent staining of LRP1 (arrowheads). Some cells negative for GFAP (stars), expressed LRP1 in the both gene-type brains. b The percentage of LRP1 positive area within a radius of 100 μm to the plaque border. c The percentage of LRP1 and GFAP double positive area. d The percentage of LRP1 positive, but GFAP negative area. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. ***P < 0.001CC BY · PubMed Central
Fig. 6 AQP4 deficiency exacerbated decreases in SYP and PSD-95 in 12-month-old APP/PS1 mice. a SYP and PSD-95 expression was markedly decreased in the hippocampus and cerebral cortex of AQP4−/−APP/PS1 mice, compared to APP/PS1 mice. b The percentage of SYP/PSD-95 positive area in the hippocampus and cortex. c Representative bands of Western bolt and d densitometry analysis of SYP and PSD-95 protein levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 6 AQP4 deficiency exacerbated decreases in SYP and PSD-95 in 12-month-old APP/PS1 mice. a SYP and PSD-95 expression was markedly decreased in the hippocampus and cerebral cortex of AQP4−/−APP/PS1 mice, compared to APP/PS1 mice. b The percentage of SYP/PSD-95 positive area in the hippocampus and cortex. c Representative bands of Western bolt and d densitometry analysis of SYP and PSD-95 protein levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001CC BY · PubMed Central
Fig. 7 AQP4 deficiency promoted decreases in BDNF production in 12-month old APP/PS1 mice. a Representative bands of Western bolt and b densitometry analysis of BDNF levels in the hippocampus and cortex. c ELISA analysis of BDNF levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 7 AQP4 deficiency promoted decreases in BDNF production in 12-month old APP/PS1 mice. a Representative bands of Western bolt and b densitometry analysis of BDNF levels in the hippocampus and cortex. c ELISA analysis of BDNF levels in the hippocampus and cortex. Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by ANOVA with post hoc Student-Newman-Keuls test. *P < 0.05; **P < 0.01; ***P < 0.001CC BY · PubMed Central
Fig. 8 AQP4 polarization was lost during the pathological progression of APP/PS1 mice. Representative AQP4 immunoreactive images of the hippocampus a andcerebral cortex b of WT mice and APP/PS1 mice at age of 3, 6.5 and 12 months. From 3 to 12 months of age, WT mice showed high AQP4 expression closely abutting the large vessels (black arrows), microvessels (green arrows) and pia surface (blue arrows), but low AQP4 expression in the adjacent parenchyma (indicated by stars). In 3-month-old APP/PS1 mice that had no Aβ plaque disposition, AQP4 expression was slightly increased at the regions immediately abutting large vessels, microvessels and pia maters as well as correspondingly adjacent parenchymal domains. At 6.5 and 12 months of age, AQP4 was markedly increased at parenchymal domains surrounding Aβ plaques, but not significantly changed at the perivascular domains. c There was no immunoreactive signal for AQP4 in the hippocampus of AQP4−/− mice and AQP4−/−APP/PS1 mice. Brain sections from WT mice were also immuno-negative when the AQP4 antibody were omitted and replaced with an equivalent concentration of normal rabbit serum. Congo Red positive plaques were only observed in the AQP4−/−APP/PS1 hippocampus. Quantitative analyses of the AQP4 polarization abutting large vessels d (n = 16–20 per mouse), microvessels e (n = 16–20 per mouse) and pia maters f (n = 4 per mouse). Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. ***P < 0.001
Fig. 8 AQP4 polarization was lost during the pathological progression of APP/PS1 mice. Representative AQP4 immunoreactive images of the hippocampus a andcerebral cortex b of WT mice and APP/PS1 mice at age of 3, 6.5 and 12 months. From 3 to 12 months of age, WT mice showed high AQP4 expression closely abutting the large vessels (black arrows), microvessels (green arrows) and pia surface (blue arrows), but low AQP4 expression in the adjacent parenchyma (indicated by stars). In 3-month-old APP/PS1 mice that had no Aβ plaque disposition, AQP4 expression was slightly increased at the regions immediately abutting large vessels, microvessels and pia maters as well as correspondingly adjacent parenchymal domains. At 6.5 and 12 months of age, AQP4 was markedly increased at parenchymal domains surrounding Aβ plaques, but not significantly changed at the perivascular domains. c There was no immunoreactive signal for AQP4 in the hippocampus of AQP4−/− mice and AQP4−/−APP/PS1 mice. Brain sections from WT mice were also immuno-negative when the AQP4 antibody were omitted and replaced with an equivalent concentration of normal rabbit serum. Congo Red positive plaques were only observed in the AQP4−/−APP/PS1 hippocampus. Quantitative analyses of the AQP4 polarization abutting large vessels d (n = 16–20 per mouse), microvessels e (n = 16–20 per mouse) and pia maters f (n = 4 per mouse). Data represent mean ± SEM from 5 to 6 mice (3–4 female, and 1–2 male) per group. The statistical analysis was performed by Student’s t-test. ***P < 0.001CC BY · PubMed Central
Fig. 9 Schematic diagram of AQP4 mitigating plaque pathogenesis in APP/PS1 mice. We propose that genetic deletion of AQP4 that mediates paravascular interstitial Aβ clearance in APP/PS1 mice results in accelerated accumulation of Aβ in brain parenchyma and cerebral blood vessels, and subsequently improves synaptic degeneration and astrocyte atrophy. In addition, extensive reactive astrocytes would impair AQP4 polarity, thus impairing the efficiency Aβ clearance from paravascular space into blood and CSF
Fig. 9 Schematic diagram of AQP4 mitigating plaque pathogenesis in APP/PS1 mice. We propose that genetic deletion of AQP4 that mediates paravascular interstitial Aβ clearance in APP/PS1 mice results in accelerated accumulation of Aβ in brain parenchyma and cerebral blood vessels, and subsequently improves synaptic degeneration and astrocyte atrophy. In addition, extensive reactive astrocytes would impair AQP4 polarity, thus impairing the efficiency Aβ clearance from paravascular space into blood and CSFCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 530

Metadata

Authors
Xu, Z., Xiao, N., Chen, Y., Huang, H., Marshall, C., Gao, J., Cai, Z., Wu, T., Hu, G., & Xiao, M.
Affiliations
  • Nanjing Medical University (CN)
  • University of Kentucky (US)
  • Hubei University of Medicine (CN)
  • Jiangsu Province Hospital (CN)
Corresponding author
Xiao, Ming
Venue
Molecular Neurodegeneration
Published
2015-11-02
Volume
10
Issue
1
Pages
58-58
ISSN
1750-1326 (ISSN-L)
OpenAlex
W1923535990
Cited by
500
References
66
Citations by year
2026: 47 · 2025: 61 · 2024: 66 · 2023: 77 · 2022: 66 · 2021: 49 · 2020: 49 · 2019: 27 · 2018: 28 · 2017: 19 · 2016: 9 · 2015: 1
FWCI
14.00
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UKnowledge (University of Kentucky) (submittedVersion, cc-by)
Funders
  • National Natural Science Foundation of China (CN) (81271210)
  • Natural Science Foundation of Jiangsu Educational Department (14KJA320001)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
aquaporin-4, amyloid-beta deposition, Alzheimer's disease, APP/PS1 mice, cerebral amyloid angiopathy, memory impairment, neuroinflammation, brain-derived neurotrophic factor, synaptic proteins, hippocampus, IL-1β
MeSH terms
Alzheimer Disease, Animals, Brain, Cognition Disorders, Inflammation, Memory Disorders, Mice, Transgenic, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Brain-Derived Neurotrophic Factor, Aquaporin 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. https://app.cochat.ai/papers/10.1186/s13024-015-0056-1
The paper
Xu, Z., Xiao, N., Chen, Y., Huang, H., Marshall, C., Gao, J., Cai, Z., Wu, T., Hu, G., & Xiao, M. (2015). Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-015-0056-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.